Compounds > cl 184005
Page last updated: 2024-09-03

cl 184005 and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

cl 184005 has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 5 studies

Compound Research Comparison

Studies
(cl 184005)		Trials
(cl 184005)		Recent Studies (post-2010)
(cl 184005)		Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
8009,156187552

Protein Interaction Comparison

ProteinTaxonomycl 184005 (IC50)1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50)
Platelet-activating factor receptorHomo sapiens (human)0.0003

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carroll, ML; DeJoy, SQ; Kerwar, SS; Kohler, CA; Oronsky, AL; Pickett, WC; Schaub, RE; Torley, LW; Wissner, A1
Connolly, RJ; Dinarello, CA; Dirkes, K; Gelfand, JA; Harris, BH; Schwaitzberg, SD1
DeJoy, SQ; Jeyaseelan, R; Kerwar, SS; Oronsky, AL; Pickett, WC; Torley, LW; Wick, MM; Wissner, A1
Dougherty, R; Johnston, P; Pickett, W; Tao, W1
Chen, J; Giris, N1

Other Studies

5 other study(ies) available for cl 184005 and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

ArticleYear
Studies of the effect of a platelet-activating factor antagonist, CL 184,005, in animal models of gram-negative bacterial sepsis.
    Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:9

    Topics: Animals; Blood Pressure; Female; Gram-Negative Bacterial Infections; Humans; Hypotension; Interleukin-6; Macaca fascicularis; Male; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Organophosphorus Compounds; Permeability; Platelet Activating Factor; Rabbits; Rats; Rats, Wistar; Thiazoles; Tumor Necrosis Factor-alpha

1992
Platelet activating factor-antagonist improves survival in experimental staphylococcal septicemia.
    Journal of pediatric surgery, 1994, Volume: 29, Issue:8

    Topics: Animals; Hemodynamics; Leukocyte Count; Organophosphorus Compounds; Platelet Activating Factor; Platelet Count; Rabbits; Sepsis; Staphylococcal Infections; Staphylococcus epidermidis; Thiazoles

1994
Effect of CL 184,005, a platelet-activating factor antagonist in a murine model of Staphylococcus aureus-induced gram-positive sepsis.
    The Journal of infectious diseases, 1994, Volume: 169, Issue:1

    Topics: Animals; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Enterotoxins; Interleukin-6; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Organophosphorus Compounds; Platelet Activating Factor; Staphylococcal Infections; Thiazoles; Time Factors; Tumor Necrosis Factor-alpha

1994
Recombinant bovine GM-CSF primes superoxide production but not degranulation induced by recombinant bovine interleukin-1 beta in bovine neutrophils.
    Journal of leukocyte biology, 1993, Volume: 53, Issue:6

    Topics: Animals; Cattle; Cell Degranulation; Glucuronidase; Granulocyte-Macrophage Colony-Stimulating Factor; Interleukin-1; Neutrophils; Organophosphorus Compounds; Platelet Activating Factor; Recombinant Proteins; Superoxides; Thiazoles

1993
Species differences in PAF receptor binding in the lungs between hamster and guinea pig.
    Journal of lipid mediators and cell signalling, 1997, Volume: 16, Issue:2

    Topics: Animals; Azepines; Binding, Competitive; Cricetinae; Fibrinolytic Agents; Guinea Pigs; Kinetics; Ligands; Lung; Male; Mesocricetus; Organophosphorus Compounds; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Species Specificity; Thiazoles; Triazoles

1997